Thursday, January 04, 2018 -- ALS is a debilitating and ultimately deadly neural disease that has few treatments and no cure.
Wednesday, January 03, 2018 -- (Reuters) - Sangamo Therapeutics Inc and Pfizer Inc said on Wednesday they would work together to develop a gene therapy to treat ALS, a disease that affects nerve cells in the brain and the spinal cord.
Thursday, January 04, 2018 -- Pfizer and Sangamo Therapeutics are linking arms to develop a potential gene therapy to treat amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD).
Friday, January 05, 2018 -- Pfizer and Sangamo plan to develop a potential gene therapy for C9orf72 ALS that aims to protect motor neurons by reducing levels of repeat-rich RNAs.
Thursday, January 04, 2018 -- Patients older than 65 were more likely to have steeper declines in slow vital capacity.